97 results on '"Keulemans, Y."'
Search Results
2. Laparoscopic cholecystectomy
- Author
-
De Wit, L. Th., Keulemans, Y., Gouma, D. J., Tytgat, Guido N. J., editor, and Mulder, Chris J. J., editor
- Published
- 1997
- Full Text
- View/download PDF
3. Use of incretin agents and risk of pancreatic cancer: a population-based cohort study
- Author
-
Knapen, L. M., van Dalem, J., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., Leufkens, H. G. M., Croes, S., Neef, C., de Vries, F., and Driessen, J. H. M.
- Published
- 2016
- Full Text
- View/download PDF
4. Pain patterns in chronic pancreatitis
- Author
-
Kempeneers, M.A., Issa, Y., Verdonk, R.C., Bruno, M., Fockens, P., Goor, H. van, Alofs, E., Bollen, T.L., Bouwense, S., Dalen, A.S.H.M. van, Dieren, S. van, Dullemen, H.M. van, Geenen, E.J. van, Hoge, C., Hooft, J.E. van, Kager, L.M., Keulemans, Y., Nooijen, L.E., Poley, J.W., Seerden, T.C.J., Tan, A., Thijs, W., Timmer, R., Vleggaar, F., Witteman, B., Ali, U.A., Besselink, M.G., Boermeester, M.A., Santvoort, H.C. van, Dutch Pancreatitis Study Grp, Graduate School, Gastroenterology and Hepatology, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Other Research, Surgery, APH - Methodology, Center for Liver, Digestive and Metabolic Diseases (CLDM), Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: FHML non-thematic output, and Gastroenterology & Hepatology
- Subjects
Male ,Bio Process Engineering ,PROGNOSIS ,Nutrition and Disease ,MULTICENTER ,GUIDELINES ,0302 clinical medicine ,Quality of life ,INSUFFICIENCY ,intractable pain ,QUALITY-OF-LIFE ,Risk Factors ,EXOCRINE ,Surveys and Questionnaires ,Voeding en Ziekte ,Longitudinal Studies ,Prospective Studies ,pancreatic surgery ,Longitudinal cohort ,Netherlands ,Pain Measurement ,medicine.diagnostic_test ,Gastroenterology ,Middle Aged ,ENDOSCOPIC TREATMENT ,Reconstructive and regenerative medicine Radboud Institute for Molecular Life Sciences [Radboudumc 10] ,030220 oncology & carcinogenesis ,Neuropathic pain ,030211 gastroenterology & hepatology ,DUCT ,Female ,medicine.medical_specialty ,Visual analogue scale ,SURGICAL DRAINAGE ,QUESTIONNAIRE ,Pain ,Other Research Radboud Institute for Molecular Life Sciences [Radboudumc 0] ,chronic pancreatitis ,03 medical and health sciences ,Internal medicine ,Pancreatitis, Chronic ,medicine ,Humans ,endoscopy ,business.industry ,medicine.disease ,Endoscopy ,Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10] ,Pain patterns ,quality of life ,Pancreatitis ,Intractable pain ,business - Abstract
ObjectivePain in chronic pancreatitis is subdivided in a continuous or intermittent pattern, each thought to represent a different entity, requiring specific treatment. Because evidence is missing, we studied pain patterns in a prospective longitudinal nationwide study.Design1131 patients with chronic pancreatitis (fulfilling M-ANNHEIM criteria) were included between 2011 and 2018 in 30 Dutch hospitals. Patients with continuous or intermittent pain were compared for demographics, pain characteristics, quality of life (Short-Form 36), imaging findings, disease duration and treatment. Alternation of pain pattern and associated variables were longitudinally assessed using a multivariable multinomial logistic regression model.ResultsAt inclusion, 589 patients (52%) had continuous pain, 231 patients (20%) had intermittent pain and 311 patients (28%) had no pain. Patients with continuous pain had more severe pain, used more opioids and neuropathic pain medication, and had a lower quality of life. There were no differences between pain patterns for morphological findings on imaging, disease duration and treatment. During a median follow-up of 47 months, 552 of 905 patients (61%) alternated at least once between pain patterns. All alternations were associated with the Visual Analogue Scale pain intensity score and surgery was only associated with the change from pain to no pain.ConclusionContinuous and intermittent pain patterns in chronic pancreatitis do not seem to be the result of distinctly different pathophysiological entities. The subjectively reported character of pain is not related to imaging findings or disease duration. Pain patterns often change over time and are merely a feature of how severity of pain is experienced.
- Published
- 2021
5. Nutritional status in patients with chronic pancreatitis
- Author
-
Verhaegh, B P M, Reijven, P L M, Prins, M H, Brouns, J H M, Masclee, A A M, and Keulemans, Y C A
- Published
- 2013
- Full Text
- View/download PDF
6. Pain patterns in chronic pancreatitis: a nationwide longitudinal cohort study
- Author
-
Kempeneers, Marinus A., Issa, Y., Verdonk, R.C., Bruno, M., Fockens, P., Goor, H. van, Alofs, E., Bollen, T.L., Bouwense, S.A., Dalen, A. van, Dieren, S. van, Dullemen, H.M. van, Geenen, E.J.M. van, Hoge, C., Hooft, Jeanin E. van, Kager, L.M., Keulemans, Y., Nooijen, L.E., Poley, J.W., Seerden, T.C., Tan, A., Thijs, W., Timmer, R., Vleggaar, F., Witteman, B., Ali, U. Ahmed, Besselink, M.G.H., Boermeester, Marja A., Santvoort, H.C. van, Kempeneers, Marinus A., Issa, Y., Verdonk, R.C., Bruno, M., Fockens, P., Goor, H. van, Alofs, E., Bollen, T.L., Bouwense, S.A., Dalen, A. van, Dieren, S. van, Dullemen, H.M. van, Geenen, E.J.M. van, Hoge, C., Hooft, Jeanin E. van, Kager, L.M., Keulemans, Y., Nooijen, L.E., Poley, J.W., Seerden, T.C., Tan, A., Thijs, W., Timmer, R., Vleggaar, F., Witteman, B., Ali, U. Ahmed, Besselink, M.G.H., Boermeester, Marja A., and Santvoort, H.C. van
- Abstract
Contains fulltext : 238452.pdf (Publisher’s version ) (Closed access), OBJECTIVE: Pain in chronic pancreatitis is subdivided in a continuous or intermittent pattern, each thought to represent a different entity, requiring specific treatment. Because evidence is missing, we studied pain patterns in a prospective longitudinal nationwide study. DESIGN: 1131 patients with chronic pancreatitis (fulfilling M-ANNHEIM criteria) were included between 2011 and 2018 in 30 Dutch hospitals. Patients with continuous or intermittent pain were compared for demographics, pain characteristics, quality of life (Short-Form 36), imaging findings, disease duration and treatment. Alternation of pain pattern and associated variables were longitudinally assessed using a multivariable multinomial logistic regression model. RESULTS: At inclusion, 589 patients (52%) had continuous pain, 231 patients (20%) had intermittent pain and 311 patients (28%) had no pain. Patients with continuous pain had more severe pain, used more opioids and neuropathic pain medication, and had a lower quality of life. There were no differences between pain patterns for morphological findings on imaging, disease duration and treatment. During a median follow-up of 47 months, 552 of 905 patients (61%) alternated at least once between pain patterns. All alternations were associated with the Visual Analogue Scale pain intensity score and surgery was only associated with the change from pain to no pain. CONCLUSION: Continuous and intermittent pain patterns in chronic pancreatitis do not seem to be the result of distinctly different pathophysiological entities. The subjectively reported character of pain is not related to imaging findings or disease duration. Pain patterns often change over time and are merely a feature of how severity of pain is experienced.
- Published
- 2021
7. The value of the Mortality in Emergency Department Sepsis (MEDS) score, C reactive protein and lactate in predicting 28-day mortality of sepsis in a Dutch emergency department
- Author
-
Hermans, M A W, Leffers, P, Jansen, L M, Keulemans, Y C, and Stassen, P M
- Published
- 2012
- Full Text
- View/download PDF
8. PERCUTANEOUS RADIOFREQUENT LESIONING OF THE SPLANCHNIC NERVES (PRFLSN) IN PATIENTS WITH CHRONIC PANCREATITIS. RESULTS OF TWELVE PROCEDURES IN EIGHT PATIENTS: 123
- Author
-
Keulemans, Y., Puylaert, M., Van Zundert, J., Kessels, F., Masclee, A., and van Kleef, M.
- Published
- 2009
- Full Text
- View/download PDF
9. Effect of Early Surgery vs Endoscopy-First Approach on Pain in Patients With Chronic Pancreatitis The ESCAPE Randomized Clinical Trial
- Author
-
Issa, Y., Kempeneers, M.A., Bruno, M.J., Fockens, P., Poley, J.W., Ali, U.A., Bollen, T.L., Busch, O.R., Dejong, C.H., Duijvendijk, P. van, Dullemen, H.M. van, Eijck, C.H. van, Goor, H. van, Hadithi, M., Haveman, J.W., Keulemans, Y., Nieuwenhuijs, V.B., Poen, A.C., Rauws, E.A., Tan, A.C., Thijs, W., Timmer, R., Witteman, B.J., Besselink, M.G., Hooft, J.E. van, Santvoort, H.C. van, Dijkgraaf, M.G., Boermeester, M.A., Honkoop, P., Thijssen, A.Y., Kooistra, T., Balkema, S., Bekkali, N., Boparai, K.S., Kager, L.M., Kloek, J.J., Takkenberg, R.B., Gouma, D.J., Gulik, T.M. van, Bemelman, W.A., Zwinderman, A.H., Bodelier, A.G.L., Seerden, T.C.J., Enckevort, C. van, Gils, N. van, Schoon, E., Vogelaar, L., Vries, R.S. de, Voorburg, A.M., Heisterkamp, J., Bezemer, G., Braat, H., Didden, P., Farahani, N., Flink, H.J., Koch, A.D., Postma, C., Putten, P.G. van, Reijnders, J.G.P., Roomer, R., Wiersema, U., Homans, G.L., Mares, W.G.N., Meiland, R., Erkelens, G.W., Maanen, H. van, Muller, G., Geenen, E. van, Perk, L.E., Raaf, J. de, Fransen, K., Hoedemaker, R., Meijssen, M.A.C., Hergelink, D.O., Munster, I.P. van, Romkes, T.E.H., Braat, A.E., Schaapherder, A.F.M., Kubben, F.J.G.M., Hoge, C., Masclee, A., Stassen, L.P.S., Brink, M.A., Vlerken, L. van, Kolkman, J.J., Venneman, N.G., Houdijk, A.P.J., Spek, B. van der, Jansen, J.M., The, O., Gerhards, M.F., Gooszen, H.G., Wilder-Smith, O., Hoekstra, J., Josemanders, D.F.G.M., Spanier, B.W.M., Boer, S.Y. de, Vries, E. de, Al-toma, A., Ramshorst, B. van, Weusten, B.L.A.M., Boerma, D., Bijlsma, A.R., Festen, E.A.M., Kerkhof, I., Kleibeuker, J.H., Kouw, E., Hofker, H.S., Ploeg, R., Beese, U., Siersema, P.D., Vleggaar, F.P., Molenaar, I.Q., Aktas, H., Guchelaar, I., Dutch Pancreatitis Study Grp, Gastroenterology & Hepatology, Surgery, RS: NUTRIM - R2 - Liver and digestive health, and MUMC+: MA Heelkunde (9)
- Subjects
medicine.medical_specialty ,Randomization ,diagnosis ,SURGICAL DRAINAGE ,duodenum-preserving resection ,Other Research Radboud Institute for Molecular Life Sciences [Radboudumc 0] ,duct ,GUIDELINES ,01 natural sciences ,law.invention ,Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18] ,03 medical and health sciences ,Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14] ,0302 clinical medicine ,Superiority Trial ,All institutes and research themes of the Radboud University Medical Center ,Quality of life ,Randomized controlled trial ,law ,Internal medicine ,medicine ,MANAGEMENT ,030212 general & internal medicine ,0101 mathematics ,Pancreatitis, chronic ,therapy ,medicine.diagnostic_test ,business.industry ,010102 general mathematics ,General Medicine ,head ,medicine.disease ,Endoscopy ,Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10] ,Pancreatitis ,Observational study ,business - Abstract
Importance: For patients with painful chronic pancreatitis, surgical treatment is postponed until medical and endoscopic treatment have failed. Observational studies have suggested that earlier surgery could mitigate disease progression, providing better pain control and preserving pancreatic function. Objective: To determine whether early surgery is more effective than the endoscopy-first approach in terms of clinical outcomes. Design, Setting, and Participants: The ESCAPE trial was an unblinded, multicenter, randomized clinical superiority trial involving 30 Dutch hospitals participating in the Dutch Pancreatitis Study Group. From April 2011 until September 2016, a total of 88 patients with chronic pancreatitis, a dilated main pancreatic duct, and who only recently started using prescribed opioids for severe pain (strong opioids for ≤2 months or weak opioids for ≤6 months) were included. The 18-month follow-up period ended in March 2018. Interventions: There were 44 patients randomized to the early surgery group who underwent pancreatic drainage surgery within 6 weeks after randomization and 44 patients randomized to the endoscopy-first approach group who underwent medical treatment, endoscopy including lithotripsy if needed, and surgery if needed. Main Outcomes and Measures: The primary outcome was pain, measured on the Izbicki pain score and integrated over 18 months (range, 0-100 [increasing score indicates more pain severity]). Secondary outcomes were pain relief at the end of follow-up; number of interventions, complications, hospital admissions; pancreatic function; quality of life (measured on the 36-Item Short Form Health Survey [SF-36]); and mortality. Results: Among 88 patients who were randomized (mean age, 52 years; 21 (24%) women), 85 (97%) completed the trial. During 18 months of follow-up, patients in the early surgery group had a lower Izbicki pain score than patients in the group randomized to receive the endoscopy-first approach group (37 vs 49; between-group difference, -12 points [95% CI, -22 to -2]; P =.02). Complete or partial pain relief at end of follow-up was achieved in 23 of 40 patients (58%) in the early surgery vs 16 of 41 (39%)in the endoscopy-first approach group (P =.10). The total number of interventions was lower in the early surgery group (median, 1 vs 3; P
- Published
- 2020
10. EFFECT OF REGULAR PHYSICAL ACTIVITY ON BOWEL MOVEMENTS IN ELDERLY PEOPLE WITH CONSTIPATION
- Author
-
Nijkamp, M W., De Schryver, A M., Keulemans, Y C., Peters, H P., Akkermans, L M., Smout, A J., de Vries, W R., and van Berge Henegouwen, G P.
- Published
- 2002
11. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial
- Author
-
Smeets, X.J.N.M., Costa, D.W. da, Fockens, P., Mulder, C.J., Timmer, R., Kievit, W., Zegers, M., Bruno, M.J., Besselink, M.G.H., Vleggaar, F.P., Hulst, R.W. van der, Poen, A.C., Heine, G.D.N., Venneman, N.G., Kolkman, J.J., Baak, L.C., Romkens, T.E.H., Dijk, S.M. van, Hallensleben, N.D., Vrie, W. van de, Seerden, T.C., Tan, A., Voorburg, A., Poley, J.W., Witteman, B.J., Bhalla, A., Hadithi, M., Thijs, W.J., Schwartz, M.P., Vrolijk, J.M., Verdonk, R.C., Delft, F. von, Keulemans, Y., Goor, H. van, Drenth, J.P.H., Geenen, E.J.M. van, Smeets, X.J.N.M., Costa, D.W. da, Fockens, P., Mulder, C.J., Timmer, R., Kievit, W., Zegers, M., Bruno, M.J., Besselink, M.G.H., Vleggaar, F.P., Hulst, R.W. van der, Poen, A.C., Heine, G.D.N., Venneman, N.G., Kolkman, J.J., Baak, L.C., Romkens, T.E.H., Dijk, S.M. van, Hallensleben, N.D., Vrie, W. van de, Seerden, T.C., Tan, A., Voorburg, A., Poley, J.W., Witteman, B.J., Bhalla, A., Hadithi, M., Thijs, W.J., Schwartz, M.P., Vrolijk, J.M., Verdonk, R.C., Delft, F. von, Keulemans, Y., Goor, H. van, Drenth, J.P.H., and Geenen, E.J.M. van
- Abstract
Contains fulltext : 190882.pdf (publisher's version ) (Open Access), BACKGROUND: Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is the most common complication of ERCP and may run a severe course. Evidence suggests that vigorous periprocedural hydration can prevent PEP, but studies to date have significant methodological drawbacks. Importantly, evidence for its added value in patients already receiving prophylactic rectal non-steroidal anti-inflammatory drugs (NSAIDs) is lacking and the cost-effectiveness of the approach has not been investigated. We hypothesize that combination therapy of rectal NSAIDs and periprocedural hydration would significantly lower the incidence of post-ERCP pancreatitis compared to rectal NSAIDs alone in moderate- to high-risk patients undergoing ERCP. METHODS: The FLUYT trial is a multicenter, parallel group, open label, superiority randomized controlled trial. A total of 826 moderate- to high-risk patients undergoing ERCP that receive prophylactic rectal NSAIDs will be randomized to a control group (no fluids or normal saline with a maximum of 1.5 mL/kg/h and 3 L/24 h) or intervention group (lactated Ringer's solution with 20 mL/kg over 60 min at start of ERCP, followed by 3 mL/kg/h for 8 h thereafter). The primary endpoint is the incidence of post-ERCP pancreatitis. Secondary endpoints include PEP severity, hydration-related complications, and cost-effectiveness. DISCUSSION: The FLUYT trial design, including hydration schedule, fluid type, and sample size, maximize its power of identifying a potential difference in post-ERCP pancreatitis incidence in patients receiving prophylactic rectal NSAIDs. TRIAL REGISTRATION: EudraCT: 2015-000829-37 . Registered on 18 February 2015. ISRCTN: 13659155 . Registered on 18 May 2015.
- Published
- 2018
12. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): Study protocol for a randomized controlled trial
- Author
-
Smeets, X.J.N.M. (Xavier J.N.M.), Da Costa, D.W. (David W.), Fockens, P. (Paul), Mulder, C.J.J. (Chris), Timmer, R. (Robin), Kievit, W. (Wietske), Zegers, M. (Marieke), Bruno, M.J. (Marco), Besselink, M.G. (Marc), Vleggaar, F.P. (Frank), Hulst, R.W.M. (René) van der, Poen, A.C. (Alexander), Heine, G.D.N. (Gerbrand D.N.), Venneman, N.G. (Niels), Kolkman, J.J. (Jeroen J.), Baak, L.C. (Lubbertus), Römkens, T.E.H., Dijk, S.M. (Sven) van, Hallensleben, N.D.L. (Nora D.L.), Vrie, W. (Wim) van de, Seerden, T.C.J. (Tom), Tan, A.C. (Adriaan), Voorburg, A.M.C.J. (Annet), Poley, J.-W. (Jan-Werner), Witteman, B.J.M. (Ben), Bhalla, A. (Abha), Hadithi, M. (Muhammed), Thijs, W.J., Schwartz, M.P. (Matthijs), Vrolijk, J.M. (Jan), Verdonk, R.C. (Robert), van Delft, F. (Foke), Keulemans, Y. (Yolande), Goor, H. (Harry) van, Drenth, J.P.H. (Joost), Geenen, E-J.M. (Erwin-Jan), Smeets, X.J.N.M. (Xavier J.N.M.), Da Costa, D.W. (David W.), Fockens, P. (Paul), Mulder, C.J.J. (Chris), Timmer, R. (Robin), Kievit, W. (Wietske), Zegers, M. (Marieke), Bruno, M.J. (Marco), Besselink, M.G. (Marc), Vleggaar, F.P. (Frank), Hulst, R.W.M. (René) van der, Poen, A.C. (Alexander), Heine, G.D.N. (Gerbrand D.N.), Venneman, N.G. (Niels), Kolkman, J.J. (Jeroen J.), Baak, L.C. (Lubbertus), Römkens, T.E.H., Dijk, S.M. (Sven) van, Hallensleben, N.D.L. (Nora D.L.), Vrie, W. (Wim) van de, Seerden, T.C.J. (Tom), Tan, A.C. (Adriaan), Voorburg, A.M.C.J. (Annet), Poley, J.-W. (Jan-Werner), Witteman, B.J.M. (Ben), Bhalla, A. (Abha), Hadithi, M. (Muhammed), Thijs, W.J., Schwartz, M.P. (Matthijs), Vrolijk, J.M. (Jan), Verdonk, R.C. (Robert), van Delft, F. (Foke), Keulemans, Y. (Yolande), Goor, H. (Harry) van, Drenth, J.P.H. (Joost), and Geenen, E-J.M. (Erwin-Jan)
- Abstract
Background: Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is the most common complication of ERCP and may run a severe course. Evidence suggests that vigorous periprocedural hydration can prevent PEP, but studies to date have significant methodological drawbacks. Importantly, evidence for its added value in patients already receiving prophylactic rectal non-steroidal anti-inflammatory drugs (NSAIDs) is lacking and the cost-effectiveness of the approach has not been investigated. We hypothesize that combination therapy of rectal NSAIDs and periprocedural hydration would significantly lower the incidence of post-ERCP pancreatitis compared to rectal NSAIDs alone in moderate- to high-risk patients undergoing ERCP. Methods: The FLUYT trial is a multicenter, parallel group, open label, superiority randomized controlled trial. A total of 826 moderate- to high-risk patients undergoing ERCP that receive prophylactic rectal NSAIDs will be randomized to a control group (no fluids or normal saline with a maximum of 1.5 mL/kg/h and 3 L/24 h) or intervention group (lactated Ringer's solution with 20 mL/kg over 60 min at start of ERCP, followed by 3 mL/kg/h for 8 h thereafter). The primary endpoint is the incidence of post-ERCP pancreatitis. Secondary endpoints include PEP severity, hydration-related complications, and cost-effectiveness. Discussion: The FLUYT trial design, including hydration schedule, fluid type, and sample size, maximize its power of identifying a potential difference in post-ERCP pancreatitis incidence in patients receiving prophylactic rectal NSAIDs.
- Published
- 2018
- Full Text
- View/download PDF
13. Fluid hydration to prevent post-ERCP pancreatitis in average-to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial
- Author
-
Smeets, X, da Costa, DW, Fockens, P, Mulder, CJJ, Timmer, R, Kievit, W, Zegers, M, Bruno, Marco, Besselink, MGH, Vleggaar, FP, van der Hulst, RWM, Poen, AC (Alexander), Heine, GDN, Venneman, NG, Kolkman, JJ, Baak, LC, Romkens, TEH, Dijk, SM, Hallensleben, Noortje, van de Vrie, W, Seerden, TCJ, Tan, A, Voorburg, A, Poley, Jan-werner, Witteman, BJ, Bhalla, A, Hadithi, M, Thijs, WJ, Schwartz, MP, Vrolijk, JM (Jan), Verdonk, RC, van Delft, F, Keulemans, Y, van Goor, H, Drenth, JPH, van Geenen, EJM, Smeets, X, da Costa, DW, Fockens, P, Mulder, CJJ, Timmer, R, Kievit, W, Zegers, M, Bruno, Marco, Besselink, MGH, Vleggaar, FP, van der Hulst, RWM, Poen, AC (Alexander), Heine, GDN, Venneman, NG, Kolkman, JJ, Baak, LC, Romkens, TEH, Dijk, SM, Hallensleben, Noortje, van de Vrie, W, Seerden, TCJ, Tan, A, Voorburg, A, Poley, Jan-werner, Witteman, BJ, Bhalla, A, Hadithi, M, Thijs, WJ, Schwartz, MP, Vrolijk, JM (Jan), Verdonk, RC, van Delft, F, Keulemans, Y, van Goor, H, Drenth, JPH, and van Geenen, EJM
- Published
- 2018
14. Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE)
- Author
-
Ahmed Ali, U., Issa, Y., Bruno, M.J., Goor, H. van, Santvoort, H.C. van, Busch, O.R., Dejong, C.H., Nieuwenhuijs, V.B., Eijck, C.H. van, Dullemen, H.M. van, Fockens, P., Siersema, P.D., Gouma, D.J., Hooft, J.E. van, Keulemans, Y., Poley, J.W., Timmer, R., Besselink, M.G., Vleggaar, F.P., Wilder-Smith, O.H.G., Gooszen, H.G., Dijkgraaf, M.G., Boermeester, M.A., Gastroenterology & Hepatology, Surgery, Internal Medicine, RS: NUTRIM - R2 - Gut-liver homeostasis, Interne Geneeskunde, Graduate School, Other departments, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA -Cancer Center Amsterdam, Gastroenterology and Hepatology, Clinical Research Unit, AII - Amsterdam institute for Infection and Immunity, and Center for Liver, Digestive and Metabolic Diseases (CLDM)
- Subjects
ALCOHOLIC CHRONIC-PANCREATITIS ,Psychological intervention ,Disease ,Severity of Illness Index ,law.invention ,Study Protocol ,Quality of life ,Randomized controlled trial ,law ,Medicine ,Pain Measurement ,Aged, 80 and over ,Gastroenterology ,Endoscopic treatment ,PAIN ,Health Care Costs ,General Medicine ,Middle Aged ,NECROSECTOMY ,Treatment Outcome ,Surgical management ,DUCT ,Evaluation of complex medical interventions Tissue engineering and pathology [NCEBP 2] ,Chronic pancreatitis ,Adult ,medicine.medical_specialty ,RESECTION ,SURGICAL DRAINAGE ,Opioid ,Risk Assessment ,ERCP ,NECROTIZING PANCREATITIS ,Early Medical Intervention ,Pancreatitis, Chronic ,Intervention (counseling) ,Pancreaticojejunostomy ,MODIFIED PUESTOW PROCEDURE ,Severity of illness ,Humans ,HEAD ,Pancreatitis, chronic ,Intensive care medicine ,Pancreas ,Aged ,business.industry ,Endoscopy ,Length of Stay ,medicine.disease ,Surgery ,Evaluation of complex medical interventions [NCEBP 2] ,SAMPLE-SIZE ,Quality of Life ,Pancreatitis ,Frey procedure ,Effective primary care and public health [DCN MP - Plasticity and memory NCEBP 7] ,Tomography, X-Ray Computed ,business ,Follow-Up Studies - Abstract
Background In current practice, patients with chronic pancreatitis undergo surgical intervention in a late stage of the disease, when conservative treatment and endoscopic interventions have failed. Recent evidence suggests that surgical intervention early on in the disease benefits patients in terms of better pain control and preservation of pancreatic function. Therefore, we designed a randomized controlled trial to evaluate the benefits, risks and costs of early surgical intervention compared to the current stepwise practice for chronic pancreatitis. Methods/design The ESCAPE trial is a randomized controlled, parallel, superiority multicenter trial. Patients with chronic pancreatitis, a dilated pancreatic duct (≥ 5 mm) and moderate pain and/or frequent flare-ups will be registered and followed monthly as potential candidates for the trial. When a registered patient meets the randomization criteria (i.e. need for opioid analgesics) the patient will be randomized to either early surgical intervention (group A) or optimal current step-up practice (group B). An expert panel of chronic pancreatitis specialists will oversee the assessment of eligibility and ensure that allocation to either treatment arm is possible. Patients in group A will undergo pancreaticojejunostomy or a Frey-procedure in case of an enlarged pancreatic head (≥ 4 cm). Patients in group B will undergo a step-up practice of optimal medical treatment, if needed followed by endoscopic interventions, and if needed followed by surgery, according to predefined criteria. Primary outcome is pain assessed with the Izbicki pain score during a follow-up of 18 months. Secondary outcomes include complications, mortality, total direct and indirect costs, quality of life, pancreatic insufficiency, alternative pain scales, length of hospital admission, number of interventions and pancreatitis flare-ups. For the sample size calculation we defined a minimal clinically relevant difference in the primary endpoint as a difference of at least 15 points on the Izbicki pain score during follow-up. To detect this difference a total of 88 patients will be randomized (alpha 0.05, power 90%, drop-out 10%). Discussion The ESCAPE trial will investigate whether early surgery in chronic pancreatitis is beneficial in terms of pain relief, pancreatic function and quality of life, compared with current step-up practice. Trial registration ISRCTN: ISRCTN45877994
- Published
- 2013
- Full Text
- View/download PDF
15. Identification of patients with upper gastrointestinal bleeding who do not need immediate treatment
- Author
-
Jansen, L.J.E.S., Leffers, P., Hermans, M., Stassen, P., Masclee, A.A.M., Keulemans, Y., Epidemiologie, Interne Geneeskunde, RS: CAPHRI School for Public Health and Primary Care, and RS: NUTRIM - R2 - Gut-liver homeostasis
- Published
- 2011
16. Dutch Chronic Pancreatitis Registry (CARE): design and rationale of a nationwide prospective evaluation and follow-up
- Author
-
Ali, U.A., Issa, Y., Goor, H. van, Eijck, C.H. van, Nieuwenhuijs, V.B., Keulemans, Y., Fockens, P., Busch, O.R., Drenth, J.P.H., Dejong, C.H., Dullemen, H.M. van, Hooft, J.E. van, Siersema, P.D., Spanier, B.W., Poley, J.W., Poen, A.C., Timmer, R., Seerden, T., Tan, A.C., Thijs, W.J., Witteman, B.J., Romkens, T.E.H., Roeterdink, A.J., Gooszen, H.G., Santvoort, H.C. van, Bruno, M.J., Boermeester, M.A., Ali, U.A., Issa, Y., Goor, H. van, Eijck, C.H. van, Nieuwenhuijs, V.B., Keulemans, Y., Fockens, P., Busch, O.R., Drenth, J.P.H., Dejong, C.H., Dullemen, H.M. van, Hooft, J.E. van, Siersema, P.D., Spanier, B.W., Poley, J.W., Poen, A.C., Timmer, R., Seerden, T., Tan, A.C., Thijs, W.J., Witteman, B.J., Romkens, T.E.H., Roeterdink, A.J., Gooszen, H.G., Santvoort, H.C. van, Bruno, M.J., and Boermeester, M.A.
- Abstract
Contains fulltext : 155080.pdf (publisher's version ) (Closed access), BACKGROUND: Chronic pancreatitis is a complex disease with many unanswered questions regarding the natural history and therapy. Prospective longitudinal studies with long-term follow-up are warranted. METHODS: The Dutch Chronic Pancreatitis Registry (CARE) is a nationwide registry aimed at prospective evaluation and follow-up of patients with chronic pancreatitis. All patients with (suspected) chronic or recurrent pancreatitis are eligible for CARE. Patients are followed-up by yearly questionnaires and review of medical records. Study outcomes are pain, disease complications, quality of life, and pancreatic function. The target sample size was set at 500 for the first year and 1000 patients within 3 years. RESULTS: A total of 1218 patients were included from February 2010 until June 2013 by 76 participating surgeons and gastroenterologist from 33 hospitals. Participation rate was 90% of eligible patients. Eight academic centers included 761 (62%) patients, while 25 community hospitals included 457 (38%). Patient centered outcomes were assessed by yearly questionnaires, which had a response rate of 85 and 82% for year 1 and 2, respectively. The median age of patients was 58 years, 814 (67%) were male, and 38% had symptoms for less than 5 years. DISCUSSION: The CARE registry has successfully recruited over 1200 patients with chronic and recurrent pancreatitis in about 3 years. The defined inclusion criteria ensure patients are included at an early disease stage. Participation and compliance rates are high. CARE offers a unique opportunity with sufficient power to investigate many clinical questions regarding natural course, complications, and efficacy and timing of treatment strategies.
- Published
- 2015
17. Dutch Chronic Pancreatitis Registry (CARE) : Design and rationale of a nationwide prospective evaluation and follow-up
- Author
-
Ali, U. Ahmed, Issa, Y., van Goor, H., van Eijck, Casper H., Nieuwenhuijs, Vincent B., Keulemans, Y., Fockens, P., Busch, O.R., Drenth, J.P., Dejong, Cornelis H., Dullemen, H.M., van Hooft, Jeanin E, Siersema, P. D., Spanier, B. W M, Poley, Jan W., Poen, Alexander C, Timmer, R., Seerden, T., Tan, Adriaan C., Thijs, Willem J., Witteman, Ben J. M., Romkens, T. E. H., Roeterdink, A. J., Gooszen, Hein G, Van Santvoort, H. C., Bruno, Marco J, Boermeester, Marja A, Ali, U. Ahmed, Issa, Y., van Goor, H., van Eijck, Casper H., Nieuwenhuijs, Vincent B., Keulemans, Y., Fockens, P., Busch, O.R., Drenth, J.P., Dejong, Cornelis H., Dullemen, H.M., van Hooft, Jeanin E, Siersema, P. D., Spanier, B. W M, Poley, Jan W., Poen, Alexander C, Timmer, R., Seerden, T., Tan, Adriaan C., Thijs, Willem J., Witteman, Ben J. M., Romkens, T. E. H., Roeterdink, A. J., Gooszen, Hein G, Van Santvoort, H. C., Bruno, Marco J, and Boermeester, Marja A
- Published
- 2015
18. Dutch Chronic Pancreatitis Registry (CARE): Design and rationale of a nationwide prospective evaluation and follow-up
- Author
-
Heelkunde Opleiding, Cancer, MS MDL 1, MS MDL Oncologie, Ali, U. Ahmed, Issa, Y., van Goor, H., van Eijck, Casper H., Nieuwenhuijs, Vincent B., Keulemans, Y., Fockens, P., Busch, O.R., Drenth, J.P., Dejong, Cornelis H., Dullemen, H.M., van Hooft, Jeanin E, Siersema, P. D., Spanier, B. W M, Poley, Jan W., Poen, Alexander C, Timmer, R., Seerden, T., Tan, Adriaan C., Thijs, Willem J., Witteman, Ben J. M., Romkens, T. E. H., Roeterdink, A. J., Gooszen, Hein G, Van Santvoort, H. C., Bruno, Marco J, Boermeester, Marja A, Heelkunde Opleiding, Cancer, MS MDL 1, MS MDL Oncologie, Ali, U. Ahmed, Issa, Y., van Goor, H., van Eijck, Casper H., Nieuwenhuijs, Vincent B., Keulemans, Y., Fockens, P., Busch, O.R., Drenth, J.P., Dejong, Cornelis H., Dullemen, H.M., van Hooft, Jeanin E, Siersema, P. D., Spanier, B. W M, Poley, Jan W., Poen, Alexander C, Timmer, R., Seerden, T., Tan, Adriaan C., Thijs, Willem J., Witteman, Ben J. M., Romkens, T. E. H., Roeterdink, A. J., Gooszen, Hein G, Van Santvoort, H. C., Bruno, Marco J, and Boermeester, Marja A
- Published
- 2015
19. Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer
- Author
-
Tol, J A M G, primary, van Hooft, J E, additional, Timmer, R, additional, Kubben, F J G M, additional, van der Harst, E, additional, de Hingh, I H J T, additional, Vleggaar, F P, additional, Molenaar, I Q, additional, Keulemans, Y C A, additional, Boerma, D, additional, Bruno, M J, additional, Schoon, E J, additional, van der Gaag, N A, additional, Besselink, M G H, additional, Fockens, P, additional, van Gulik, T M, additional, Rauws, E A J, additional, Busch, O R C, additional, and Gouma, D J, additional
- Published
- 2015
- Full Text
- View/download PDF
20. Patiënten met bovenbuikklachten en echografisch aangetoonde galstenen: beginnen met een expectatief beleid
- Author
-
van der Vlies, C. H., Keulemans, Y. C. A., Gouma, D. J., Boermeester, M. A., Surgery, Amsterdam institute for Infection and Immunity, and Amsterdam Gastroenterology Endocrinology Metabolism
- Abstract
Three patients, two women aged 33 and 75 years and a 62-year-old man, presented with gallstones and upper abdominal pain due to functional dyspepsia, chronic constipation, and oesophageal spasm, respectively. After a period of watchful waiting, the first patient insisted on having a cholecystectomy, but her complaints persisted. In the second patient, the complaints disappeared after treatment with a bulking agent and magnesium oxide. The third patient received medication as well: a proton-pump inhibitor, prokinetic agents, a calcium antagonist and Helicobacter eradication, and recovered. The presence of gallstones is relatively easy to assess by ultrasound imaging, but the decision whether abdominal symptoms are related to gallbladder stones remains a diagnostic challenge for the clinician. The key question for the family practitioner, gastroenterologist and surgeon is which patients with upper abdominal pain and proven gallbladder stones might benefit from a cholecystectomy. The patients described illustrate that upper abdominal pain is not invariably related to symptomatic gallbladder disease. The published evidence supports initial watchful waiting with additional diagnostic investigation, and cholecystectomy only later if judged to be necessary
- Published
- 2007
21. Na endoscopische sphincterotomie voor choledochusstenen meer recidiefklachten bij afwachtend beleid dan bij geplande laparoscopische cholecystectomie; gerandomiseerde klinische trial
- Author
-
Boerma, D., Rauws, E. A. J., Keulemans, Y. C. A., Janssen, I. M. C., Bolwerk, C. J. M., Timmer, R., Boerma, E. J., Obertop, H., Huibregtse, K., Gouma, D. J., Gastroenterology and Hepatology, and Surgery
- Published
- 2002
22. Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE): design and rationale of a randomized trial
- Author
-
Ahmed Ali, U., Issa, Y., Bruno, M.J., Goor, H. van, Santvoort, H.C. van, Busch, O.R., Dejong, C.H., Nieuwenhuijs, V.B., Eijck, C.H. van, Dullemen, H.M. van, Fockens, P., Siersema, P.D., Gouma, D.J., Hooft, J.E. van, Keulemans, Y., Poley, J.W., Timmer, R., Besselink, M.G., Vleggaar, F.P., Wilder-Smith, O.H.G., Gooszen, H.G., Dijkgraaf, M.G., Boermeester, M.A., et al., Ahmed Ali, U., Issa, Y., Bruno, M.J., Goor, H. van, Santvoort, H.C. van, Busch, O.R., Dejong, C.H., Nieuwenhuijs, V.B., Eijck, C.H. van, Dullemen, H.M. van, Fockens, P., Siersema, P.D., Gouma, D.J., Hooft, J.E. van, Keulemans, Y., Poley, J.W., Timmer, R., Besselink, M.G., Vleggaar, F.P., Wilder-Smith, O.H.G., Gooszen, H.G., Dijkgraaf, M.G., Boermeester, M.A., and et al.
- Abstract
Contains fulltext : 118332.pdf (publisher's version ) (Open Access), BACKGROUND: In current practice, patients with chronic pancreatitis undergo surgical intervention in a late stage of the disease, when conservative treatment and endoscopic interventions have failed. Recent evidence suggests that surgical intervention early on in the disease benefits patients in terms of better pain control and preservation of pancreatic function. Therefore, we designed a randomized controlled trial to evaluate the benefits, risks and costs of early surgical intervention compared to the current stepwise practice for chronic pancreatitis. METHODS/DESIGN: The ESCAPE trial is a randomized controlled, parallel, superiority multicenter trial. Patients with chronic pancreatitis, a dilated pancreatic duct (>/= 5 mm) and moderate pain and/or frequent flare-ups will be registered and followed monthly as potential candidates for the trial. When a registered patient meets the randomization criteria (i.e. need for opioid analgesics) the patient will be randomized to either early surgical intervention (group A) or optimal current step-up practice (group B). An expert panel of chronic pancreatitis specialists will oversee the assessment of eligibility and ensure that allocation to either treatment arm is possible. Patients in group A will undergo pancreaticojejunostomy or a Frey-procedure in case of an enlarged pancreatic head (>/= 4 cm). Patients in group B will undergo a step-up practice of optimal medical treatment, if needed followed by endoscopic interventions, and if needed followed by surgery, according to predefined criteria. Primary outcome is pain assessed with the Izbicki pain score during a follow-up of 18 months. Secondary outcomes include complications, mortality, total direct and indirect costs, quality of life, pancreatic insufficiency, alternative pain scales, length of hospital admission, number of interventions and pancreatitis flare-ups. For the sample size calculation we defined a minimal clinically relevant difference in the primary endpoint
- Published
- 2013
23. Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE): Design and rationale of a randomized trial
- Author
-
Ahmed Ali, U. (Usama), Issa, Y. (Yama), Bruno, M.J. (Marco), Goor, H. (Harry) van, Santvoort, H.C. (Hjalmar) van, Busch, O.R.C. (Olivier), Dejong, C.H. (Cees), Nieuwenhuijs, V.B. (Vincent), Eijck, C.H.J. (Casper) van, Dullemen, H.M. (Hendrik) van, Fockens, P. (Paul), Siersema, P.D. (Peter), Gouma, D.J. (Dirk), Hooft, J.E. (Jeanin) van, Keulemans, Y. (Yolande), Poley, J.-W. (Jan-Werner), Timmer, R. (Robin), Besselink, M.G. (Marc), Vleggaar, F.P. (Frank), Wilder-Smith, O.H. (O.), Gooszen, H.G. (Hein), Dijkgraaf, M.G.W. (Marcel), Boermeester, M.A. (Marja), Ahmed Ali, U. (Usama), Issa, Y. (Yama), Bruno, M.J. (Marco), Goor, H. (Harry) van, Santvoort, H.C. (Hjalmar) van, Busch, O.R.C. (Olivier), Dejong, C.H. (Cees), Nieuwenhuijs, V.B. (Vincent), Eijck, C.H.J. (Casper) van, Dullemen, H.M. (Hendrik) van, Fockens, P. (Paul), Siersema, P.D. (Peter), Gouma, D.J. (Dirk), Hooft, J.E. (Jeanin) van, Keulemans, Y. (Yolande), Poley, J.-W. (Jan-Werner), Timmer, R. (Robin), Besselink, M.G. (Marc), Vleggaar, F.P. (Frank), Wilder-Smith, O.H. (O.), Gooszen, H.G. (Hein), Dijkgraaf, M.G.W. (Marcel), and Boermeester, M.A. (Marja)
- Abstract
Background: In current practice, patients with chronic pancreatitis undergo surgical intervention in a late stage of the disease, when conservative treatment and endoscopic interventions have failed. Recent evidence suggests that surgical intervention early on in the disease benefits patients in terms of better pain control and preservation of pancreatic function. Therefore, we designed a randomized controlled trial to evaluate the benefits, risks and costs of early surgical intervention compared to the current stepwise practice for chronic pancreatitis.Methods/design: The ESCAPE trial is a randomized controlled, parallel, superiority multicenter trial. Patients with chronic pancreatitis, a dilated pancreatic duct (≥ 5 mm) and moderate pain and/or frequent flare-ups will be registered and followed monthly as potential candidates for the trial. When a registered patient meets the randomization criteria (i.e. need for opioid analgesics) the patient will be randomized to either early surgical intervention (group A) or optimal current step-up practice (group B). An expert panel of chronic pancreatitis specialists will oversee the assessment of eligibility and ensure that allocation to either treatment arm is possible. Patients in group A will undergo pancreaticojejunostomy or a Frey-procedure in case of an enlarged pancreatic head (≥ 4 cm). Patients in group B will undergo a step-up practice of optimal medical treatment, if needed followed by endoscopic interventions, and if needed followed by surgery, according to predefined criteria. Primary outcome is pain assessed with the Izbicki pain score during a follow-up of 18 months. Secondary outcomes include complications, mortality, total direct and indirect costs, quality of life, pancreatic insufficiency, alternative pain scales, length of hospital admission, number of interventions and pancreatitis flare-ups. For the sample size calculation we defined a minimal clinically relevant difference in the primary endpoint as a
- Published
- 2013
- Full Text
- View/download PDF
24. Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE): design and rationale of a randomized trial
- Author
-
Ali, UA, Issa, Y, Bruno, Marco, van Goor, H, van Santvoort, H, Busch, ORC, Dejong, CHC, Nieuwenhuijs, VB, van Eijck, Casper, van Dullemen, HM, Fockens, P, Siersema, PD (Peter), Gouma, DJ, van Hooft, JE, Keulemans, Y, Poley, Jan-werner, Timmer, R, Besselink, MG, Vleggaar, FP, Wilder-Smith, OH, Gooszen, HG, Dijkgraaf, MGW, Boermeester, MA, Ali, UA, Issa, Y, Bruno, Marco, van Goor, H, van Santvoort, H, Busch, ORC, Dejong, CHC, Nieuwenhuijs, VB, van Eijck, Casper, van Dullemen, HM, Fockens, P, Siersema, PD (Peter), Gouma, DJ, van Hooft, JE, Keulemans, Y, Poley, Jan-werner, Timmer, R, Besselink, MG, Vleggaar, FP, Wilder-Smith, OH, Gooszen, HG, Dijkgraaf, MGW, and Boermeester, MA
- Published
- 2013
25. Galwegletsel na laparoscopische cholecystectomie
- Author
-
Gouma, D. J., Rauws, E. A., Keulemans, Y. C., Bergman, J. J., Huibregtse, K., Obertop, H., and Other departments
- Subjects
digestive system - Abstract
Eight years after the introduction of laparoscopic cholecystectomy a decrease of the incidence of bile duct injuries is reported in the literature. The incidence of a bile duct injury after laparoscopic cholecystectomy is now slightly higher than after open cholecystectomy. A minority of these injuries are detected during surgery. Most patients have a delayed identification of the bile duct injury, even after discharge from the hospital. An early diagnostic work-up with ultrasound and endoscopic retrograde cholangiopancreatography (ERCP) is mandatory in every patient with persisting symptoms (more than 48 hours) after laparoscopic cholecystectomy. Still, one-third of the patients are subjected to a 'diagnostic' exploratory laparotomy without preoperative visualization of the biliary tract by ERCP or percutaneous transhepatic cholangiography. Minor lesions are mostly treated successfully by endoscopy with a stent. After transection of the bile duct surgical reconstruction by a hepaticojejunostomy has to be performed. A delayed elective reconstruction was associated with fewer complications than acute repair under suboptimal circumstances such as local inflammatory changes and bile leakage
- Published
- 1999
26. Diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands
- Author
-
Eijgenraam, P, primary, Heinen, M M, additional, Verhage, B A J, additional, Keulemans, Y C, additional, Schouten, L J, additional, and van den Brandt, P A, additional
- Published
- 2013
- Full Text
- View/download PDF
27. Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer.
- Author
-
Tol, J. A. M. G., van Hooft, J. E., Timmer, R., Kubben, F. J. G. M., van der Harst, E., de Hingh, I. H. J. T., Vleggaar, F. P., Molenaar, I. Q., Keulemans, Y. C. A., Boerma, D., Bruno, M. J., Schoon, E. J., van der Gaag, N. A., Besselink, M. G. H., Fockens, P., van Gulik, T. M., Rauws, E. A. J., Busch, O. R. C., and Gouma, D. J.
- Subjects
PANCREATIC cancer treatment ,SURGICAL stents ,PREOPERATIVE period ,BILIOUS diseases & biliousness ,SURGICAL excision ,ONCOLOGIC surgery - Published
- 2016
- Full Text
- View/download PDF
28. Is 24-hour observation after laparoscopic cholecystectomy important for the identification of major vascular injury?
- Author
-
Keulemans, Y. C., Gouma, D. J., and Other departments
- Published
- 1997
29. The value of the Mortality in Emergency Department Sepsis (MEDS) score, C reactive protein and lactate in predicting 28-day mortality of sepsis in a Dutch emergency department
- Author
-
Hermans, M A W, primary, Leffers, P, additional, Jansen, L M, additional, Keulemans, Y C, additional, and Stassen, P M, additional
- Published
- 2011
- Full Text
- View/download PDF
30. 123 PERCUTANEOUS RADIOFREQUENT LESIONING OF THE SPLANCHNIC NERVES (PRFLSN) IN PATIENTS WITH CHRONIC PANCREATITIS. RESULTS OF TWELVE PROCEDURES IN EIGHT PATIENTS
- Author
-
Keulemans, Y., primary, Puylaert, M., additional, Zundert, J., additional, Kessels, F., additional, Masclee, A., additional, and Kleef, M., additional
- Published
- 2009
- Full Text
- View/download PDF
31. New Strategies for the Treatment of Gallstone Disease
- Author
-
Keulemans, Y. C. A., primary, Venneman, N. G., additional, Gouma, D. J., additional, and Henegouwen, G. P. van Berge, additional
- Published
- 2002
- Full Text
- View/download PDF
32. Enterohepatic cycling of bilirubin: A putative mechanism for pigment gallstone formation in ileal Crohn's disease☆, ☆☆
- Author
-
BRINK, M, primary, SLORS, J, additional, KEULEMANS, Y, additional, MOK, K, additional, DEWAART, D, additional, CAREY, M, additional, GROEN, A, additional, and TYTGAT, G, additional
- Published
- 1999
- Full Text
- View/download PDF
33. Day care or hospital admission after laparoscopic cholecystectomy, a prospective randomized trial
- Author
-
Keulemans, Y. C.A., primary, Eshuis, J. H., additional, De Haes, J. C.J.M., additional, Leeuwenberg, A., additional, de Wit, L. Th., additional, and Gouma, DJ., additional
- Published
- 1998
- Full Text
- View/download PDF
34. A comparison of cholesterol crystalization-controlling factors in gallbladder biles from chilean and dutch gallstone patients
- Author
-
Miguel, J-F, primary, Nervi, F., additional, Keulemans, Y., additional, Mok, K.S., additional, and Groen, A.K., additional
- Published
- 1998
- Full Text
- View/download PDF
35. The role of the Concanavalin A-binding fraction in cholesterol crystallization in native human bile
- Author
-
Keulemans, Y. C. A., Mok, K. S., Gouma, D. J., and Groen, A. K.
- Published
- 1997
- Full Text
- View/download PDF
36. THE TREATMENT STRATEGY OF THE GALLBLADDER AFTER ENDOSCOPIC SPHINCTEROTOMY.
- Author
-
Keulemans, Y. C. A., Rauws, E. A. J., Huibregtse, K., and Gouma, D. J.
- Published
- 1996
37. Long-Term Outcomes of Early Surgery vs Endoscopy First in Chronic Pancreatitis: Follow-Up Analysis of the ESCAPE Randomized Clinical Trial.
- Author
-
van Veldhuisen CL, Kempeneers MA, de Rijk FEM, Bouwense SA, Bruno MJ, Fockens P, Poley JW, Ali UA, Bollen TL, Busch OR, van Duijvendijk P, van Dullemen HM, van Eijck CH, Van Goor H, Hadithi M, Haveman JW, Keulemans Y, Nieuwenhuijs VB, Poen AC, Voermans RP, Tan AC, Thijs W, Verdonk RC, Witteman BJ, van Hooft JE, van Santvoort HC, Dijkgraaf MG, Besselink MG, Boermeester MA, and Issa Y
- Abstract
Importance: Patients with painful chronic pancreatitis and a dilated pancreatic duct can be treated by early surgery or an endoscopy-first approach., Objective: To compare long-term clinical outcomes of early surgery vs an endoscopy-first approach using follow-up data from the ESCAPE randomized clinical trial., Design, Setting, and Participants: Between April 2011 and September 2018, 88 patients with painful chronic pancreatitis were randomly assigned to early surgery or an endoscopy-first approach in 30 hospitals in the Netherlands collaborating in the Dutch Pancreatitis Study Group as part of the ESCAPE randomized clinical trial. For the present cohort study, long-term clinical data were collected after the initial 18-month follow-up. Follow-up was completed in June 2022, and data analysis was performed in June 2023., Exposure: Patients with chronic pancreatitis were randomly assigned to early surgery or an endoscopy-first approach., Main Outcomes and Measures: The primary end point was pain, assessed by the Izbicki pain score; secondary end points included patient-reported complete pain relief and satisfaction. Predefined subgroups included patients who progressed from endoscopy to surgery and those with ductal clearance obtained by endoscopy. Analysis was performed according to the intention-to-treat principle., Results: In this cohort study, 86 of 88 overall patients could be evaluated, with a mean (SD) follow-up period of 98 (16) months. Of 88 initial patients, 21 patients (24%) were female, and mean (SD) patient age was 61 (10) years. At the end of long-term follow-up, the mean (SD) Izbicki pain score was significant lower (33 [31] vs 51 [31]) in the early surgery group, as was the rate of patient-reported complete pain relief (14 of 31 patients [45%] vs 6 of 30 patients [20%]), compared to the endoscopy-first group. After the initial 18-month follow-up, 11 of 43 patients in the early surgery group (26%) underwent reinterventions vs 19 of 43 patients in the endoscopy-first group (44%). At the end of follow-up, more patients in the early surgery group were "very satisfied" with their treatment (22 of 31 patients [71%] vs 10 of 30 patients [33%]). Patients who progressed from endoscopy to surgery (22 of 43 patients [51%]) had significantly worse mean (SD) Izbicki pain scores (33 [31] vs 52 [24]) compared to the early surgery group and had a lower rate of complete pain relief (55% for early surgery vs 12% for endoscopy first). In the endoscopy-first group, patients with endoscopic ductal clearance had similar mean (SD) Izbicki pain scores as the remaining patients (49 [34] vs 53 [28])., Conclusions and Relevance: In this cohort study evaluating long-term outcomes of the ESCAPE randomized clinical trial, after approximately 8 years of follow-up, early surgery was superior to an endoscopy-first approach in patients with painful chronic pancreatitis and a dilated main pancreatic duct in pain scores and patient satisfaction. Notably, patients who progressed from endoscopy to surgery had worse outcomes compared to patients undergoing early surgery, and obtaining endoscopic ductal clearance did not improve outcomes.
- Published
- 2024
- Full Text
- View/download PDF
38. Pain patterns in chronic pancreatitis: a nationwide longitudinal cohort study.
- Author
-
Kempeneers MA, Issa Y, Verdonk RC, Bruno M, Fockens P, van Goor H, Alofs E, Bollen TL, Bouwense S, van Dalen ASHM, van Dieren S, van Dullemen HM, van Geenen EJ, Hoge C, van Hooft JE, Kager LM, Keulemans Y, Nooijen LE, Poley JW, Seerden TCJ, Tan A, Thijs W, Timmer R, Vleggaar F, Witteman B, Ahmed Ali U, Besselink MG, Boermeester MA, and van Santvoort HC
- Subjects
- Female, Humans, Longitudinal Studies, Male, Middle Aged, Netherlands epidemiology, Pain epidemiology, Pain Measurement, Prospective Studies, Risk Factors, Surveys and Questionnaires, Pain etiology, Pancreatitis, Chronic complications
- Abstract
Objective: Pain in chronic pancreatitis is subdivided in a continuous or intermittent pattern, each thought to represent a different entity, requiring specific treatment. Because evidence is missing, we studied pain patterns in a prospective longitudinal nationwide study., Design: 1131 patients with chronic pancreatitis (fulfilling M-ANNHEIM criteria) were included between 2011 and 2018 in 30 Dutch hospitals. Patients with continuous or intermittent pain were compared for demographics, pain characteristics, quality of life (Short-Form 36), imaging findings, disease duration and treatment. Alternation of pain pattern and associated variables were longitudinally assessed using a multivariable multinomial logistic regression model., Results: At inclusion, 589 patients (52%) had continuous pain, 231 patients (20%) had intermittent pain and 311 patients (28%) had no pain. Patients with continuous pain had more severe pain, used more opioids and neuropathic pain medication, and had a lower quality of life. There were no differences between pain patterns for morphological findings on imaging, disease duration and treatment. During a median follow-up of 47 months, 552 of 905 patients (61%) alternated at least once between pain patterns. All alternations were associated with the Visual Analogue Scale pain intensity score and surgery was only associated with the change from pain to no pain., Conclusion: Continuous and intermittent pain patterns in chronic pancreatitis do not seem to be the result of distinctly different pathophysiological entities. The subjectively reported character of pain is not related to imaging findings or disease duration. Pain patterns often change over time and are merely a feature of how severity of pain is experienced., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
39. Effect of Early Surgery vs Endoscopy-First Approach on Pain in Patients With Chronic Pancreatitis: The ESCAPE Randomized Clinical Trial.
- Author
-
Issa Y, Kempeneers MA, Bruno MJ, Fockens P, Poley JW, Ahmed Ali U, Bollen TL, Busch OR, Dejong CH, van Duijvendijk P, van Dullemen HM, van Eijck CH, van Goor H, Hadithi M, Haveman JW, Keulemans Y, Nieuwenhuijs VB, Poen AC, Rauws EA, Tan AC, Thijs W, Timmer R, Witteman BJ, Besselink MG, van Hooft JE, van Santvoort HC, Dijkgraaf MG, and Boermeester MA
- Subjects
- Adult, Analgesics, Opioid therapeutic use, Area Under Curve, Calculi surgery, Female, Humans, Male, Middle Aged, Pain etiology, Pain Measurement, Pancreatitis, Chronic complications, Pancreatitis, Chronic surgery, Calculi therapy, Drainage, Endoscopy, Lithotripsy, Pain Management methods, Pancreatic Ducts surgery, Pancreatitis, Chronic therapy
- Abstract
Importance: For patients with painful chronic pancreatitis, surgical treatment is postponed until medical and endoscopic treatment have failed. Observational studies have suggested that earlier surgery could mitigate disease progression, providing better pain control and preserving pancreatic function., Objective: To determine whether early surgery is more effective than the endoscopy-first approach in terms of clinical outcomes., Design, Setting, and Participants: The ESCAPE trial was an unblinded, multicenter, randomized clinical superiority trial involving 30 Dutch hospitals participating in the Dutch Pancreatitis Study Group. From April 2011 until September 2016, a total of 88 patients with chronic pancreatitis, a dilated main pancreatic duct, and who only recently started using prescribed opioids for severe pain (strong opioids for ≤2 months or weak opioids for ≤6 months) were included. The 18-month follow-up period ended in March 2018., Interventions: There were 44 patients randomized to the early surgery group who underwent pancreatic drainage surgery within 6 weeks after randomization and 44 patients randomized to the endoscopy-first approach group who underwent medical treatment, endoscopy including lithotripsy if needed, and surgery if needed., Main Outcomes and Measures: The primary outcome was pain, measured on the Izbicki pain score and integrated over 18 months (range, 0-100 [increasing score indicates more pain severity]). Secondary outcomes were pain relief at the end of follow-up; number of interventions, complications, hospital admissions; pancreatic function; quality of life (measured on the 36-Item Short Form Health Survey [SF-36]); and mortality., Results: Among 88 patients who were randomized (mean age, 52 years; 21 (24%) women), 85 (97%) completed the trial. During 18 months of follow-up, patients in the early surgery group had a lower Izbicki pain score than patients in the group randomized to receive the endoscopy-first approach group (37 vs 49; between-group difference, -12 points [95% CI, -22 to -2]; P = .02). Complete or partial pain relief at end of follow-up was achieved in 23 of 40 patients (58%) in the early surgery vs 16 of 41 (39%)in the endoscopy-first approach group (P = .10). The total number of interventions was lower in the early surgery group (median, 1 vs 3; P < .001). Treatment complications (27% vs 25%), mortality (0% vs 0%), hospital admissions, pancreatic function, and quality of life were not significantly different between early surgery and the endoscopy-first approach., Conclusions and Relevance: Among patients with chronic pancreatitis, early surgery compared with an endoscopy-first approach resulted in lower pain scores when integrated over 18 months. However, further research is needed to assess persistence of differences over time and to replicate the study findings., Trial Registration: ISRCTN Identifier: ISRCTN45877994.
- Published
- 2020
- Full Text
- View/download PDF
40. Improving nutritional status assessment in patients with chronic pancreatitis.
- Author
-
Hintaran AD, Chenault MN, Verhaegh BPM, Reijven PLM, Masclee AAM, and Keulemans YCA
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Nutrition Assessment, Nutritional Status, Pancreatitis, Chronic pathology, Pancreatitis, Chronic therapy
- Abstract
Introduction: Chronic pancreatitis (CP) is a progressive inflammatory disorder causing irreversible destruction of pancreatic tissue, leading to malnutrition. A previous study has found that currently used screening methods (periodic recording of body weight and faecal and serological markers) fall short in identifying and curbing malnutrition. Moreover, data is lacking regarding change in nutritional status over time. The aim of our study is to investigate changes in nutritional status in CP patients over time and to determine whether a more extensive set of measurements would be beneficial for nutritional screening of these patients., Methods: CP patients who had undergone a nutritional assessment in 2012 were recruited to undergo a second assessment. The assessment consisted of anthropometric measurements, bioelectrical impedance analysis (BIA), handgrip strength (HGS), the Mini Nutritional Assessment (MNA), determination of faecal and serological markers and the Short Form Health (SF-36) questionnaire. These two assessments were compared and correlations between the various measures were calculated., Results: Twenty-eight patients underwent a second assessment. An increase in fat mass and a decrease in both fat free mass (FFM) and HGS were observed. The number of patients scoring under the 10th percentile for FFM (43%-54%) and HGS in their dominant side (38%-46%) increased. FFM and HGS were positively correlated (R = 0.57)., Conclusion: Even though current guidelines for CP follow-up were adhered to, there was a general deterioration in nutritional status. HGS correlated with FFM. HGS might be useful as a screening instrument for malnutrition in CP patients., (Copyright © 2017 IAP and EPC. Published by Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
41. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.
- Author
-
Smeets XJNM, da Costa DW, Fockens P, Mulder CJJ, Timmer R, Kievit W, Zegers M, Bruno MJ, Besselink MGH, Vleggaar FP, van der Hulst RWM, Poen AC, Heine GDN, Venneman NG, Kolkman JJ, Baak LC, Römkens TEH, van Dijk SM, Hallensleben NDL, van de Vrie W, Seerden TCJ, Tan ACITL, Voorburg AMCJ, Poley JW, Witteman BJ, Bhalla A, Hadithi M, Thijs WJ, Schwartz MP, Vrolijk JM, Verdonk RC, van Delft F, Keulemans Y, van Goor H, Drenth JPH, and van Geenen EJM
- Subjects
- Administration, Rectal, Adult, Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Data Collection, Humans, Middle Aged, Multicenter Studies as Topic, Ringer's Lactate adverse effects, Sample Size, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Pancreatitis prevention & control, Randomized Controlled Trials as Topic, Ringer's Lactate administration & dosage
- Abstract
Background: Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is the most common complication of ERCP and may run a severe course. Evidence suggests that vigorous periprocedural hydration can prevent PEP, but studies to date have significant methodological drawbacks. Importantly, evidence for its added value in patients already receiving prophylactic rectal non-steroidal anti-inflammatory drugs (NSAIDs) is lacking and the cost-effectiveness of the approach has not been investigated. We hypothesize that combination therapy of rectal NSAIDs and periprocedural hydration would significantly lower the incidence of post-ERCP pancreatitis compared to rectal NSAIDs alone in moderate- to high-risk patients undergoing ERCP., Methods: The FLUYT trial is a multicenter, parallel group, open label, superiority randomized controlled trial. A total of 826 moderate- to high-risk patients undergoing ERCP that receive prophylactic rectal NSAIDs will be randomized to a control group (no fluids or normal saline with a maximum of 1.5 mL/kg/h and 3 L/24 h) or intervention group (lactated Ringer's solution with 20 mL/kg over 60 min at start of ERCP, followed by 3 mL/kg/h for 8 h thereafter). The primary endpoint is the incidence of post-ERCP pancreatitis. Secondary endpoints include PEP severity, hydration-related complications, and cost-effectiveness., Discussion: The FLUYT trial design, including hydration schedule, fluid type, and sample size, maximize its power of identifying a potential difference in post-ERCP pancreatitis incidence in patients receiving prophylactic rectal NSAIDs., Trial Registration: EudraCT: 2015-000829-37 . Registered on 18 February 2015., Isrctn: 13659155 . Registered on 18 May 2015.
- Published
- 2018
- Full Text
- View/download PDF
42. Identification of patients with upper gastrointestinal bleeding who do not need immediate treatment.
- Author
-
Jansen L, Leffers P, Hermans M, Stassen P, Masclee A, and Keulemans Y
- Subjects
- Adult, Aged, Aged, 80 and over, Emergencies, Female, Humans, Male, Middle Aged, Predictive Value of Tests, ROC Curve, Gastrointestinal Hemorrhage diagnosis, Gastrointestinal Hemorrhage therapy, Triage
- Published
- 2011
43. [Patients with upper abdominal pain and echographically-proven gallstones: start with expectative management].
- Author
-
van der Vlies CH, Keulemans YC, Gouma DJ, and Boermeester MA
- Subjects
- Adult, Aged, Constipation complications, Constipation drug therapy, Diagnosis, Differential, Dyspepsia complications, Esophageal Spasm, Diffuse complications, Esophageal Spasm, Diffuse drug therapy, Female, Gallstones surgery, Humans, Male, Middle Aged, Treatment Failure, Treatment Outcome, Ultrasonography, Abdominal Pain diagnosis, Abdominal Pain etiology, Cholecystectomy methods, Gallstones diagnostic imaging
- Abstract
Three patients, two women aged 33 and 75 years and a 62-year-old man, presented with gallstones and upper abdominal pain due to functional dyspepsia, chronic constipation, and oesophageal spasm, respectively. After a period of watchful waiting, the first patient insisted on having a cholecystectomy, but her complaints persisted. In the second patient, the complaints disappeared after treatment with a bulking agent and magnesium oxide. The third patient received medication as well: a proton-pump inhibitor, prokinetic agents, a calcium antagonist and Helicobacter eradication, and recovered. The presence of gallstones is relatively easy to assess by ultrasound imaging, but the decision whether abdominal symptoms are related to gallbladder stones remains a diagnostic challenge for the clinician. The key question for the family practitioner, gastroenterologist and surgeon is which patients with upper abdominal pain and proven gallbladder stones might benefit from a cholecystectomy. The patients described illustrate that upper abdominal pain is not invariably related to symptomatic gallbladder disease. The published evidence supports initial watchful waiting with additional diagnostic investigation, and cholecystectomy only later if judged to be necessary.
- Published
- 2007
44. [Unexplained vague abdominal complaints in adults: indication for CT in case of suspected intussusception].
- Author
-
van Ooteghem NA and Keulemans YC
- Subjects
- Humans, Intussusception diagnostic imaging, Radiography, Sensitivity and Specificity, Carcinoembryonic Antigen analysis, Intussusception diagnosis
- Published
- 2003
45. Impaired quality of life 5 years after bile duct injury during laparoscopic cholecystectomy: a prospective analysis.
- Author
-
Boerma D, Rauws EA, Keulemans YC, Bergman JJ, Obertop H, Huibregtse K, and Gouma DJ
- Subjects
- Adult, Bile Ducts surgery, Female, Follow-Up Studies, Health Status, Humans, Male, Middle Aged, Prospective Studies, Reoperation, Risk Factors, Bile Ducts injuries, Cholecystectomy, Laparoscopic adverse effects, Intraoperative Complications, Quality of Life
- Abstract
Objective: To assess the impact of bile duct injury (BDI) sustained during laparoscopic cholecystectomy on physical and mental quality of life (QOL)., Summary Background Data: The incidence of BDI during laparoscopic cholecystectomy has decreased but remains as high as 1.4%. Data on the long-term outcome of treatment in these patients are scarce, and QOL after BDI is unknown., Methods: One hundred six consecutive patients (75 women, median age 44 +/- 14 years) were referred between 1990 and 1996 for treatment of BDI sustained during laparoscopic cholecystectomy. Outcome was evaluated according to the type of treatment used (endoscopic or surgical) and the type of injury. Objective outcome (interventions, hospital admissions, laboratory data) was evaluated, a questionnaire was filled out, and a QOL survey was performed (using the SF-36). Risk factors for a worse outcome were calculated., Results: Median follow-up time was 70 months (range 37-110). The objective outcome of endoscopic treatment (n = 69) was excellent (94%). The result of surgical treatment (n = 31) depended on the timing of reconstruction (overall success 84%; in case of delayed hepaticojejunostomy 94%). Five patients underwent interventional radiology with a good outcome. Despite this excellent objective outcome, QOL appeared to be both physically and mentally reduced compared with controls (P <.05) and was not dependent on the type of treatment used or the severity of the injury. The duration of the treatment was independently prognostic for a worse mental QOL., Conclusions: Despite the excellent functional outcome after repair, the occurrence of a BDI has a great impact on the patient's physical and mental QOL, even at long-term follow-up.
- Published
- 2001
- Full Text
- View/download PDF
46. Concanavalin A-binding cholesterol crystallization inhibiting and promoting activity in bile from patients with Crohn's disease compared to patients with ulcerative colitis.
- Author
-
Keulemans YC, Mok KS, Slors JF, Brink MA, Gouma DJ, Tytgat GN, and Groen AK
- Subjects
- Adult, Bile metabolism, Crystallization, Female, Gallbladder metabolism, Humans, Immunoglobulin A metabolism, Lipid Metabolism, Male, Secretory Component metabolism, Cholesterol metabolism, Colitis, Ulcerative metabolism, Concanavalin A metabolism, Crohn Disease metabolism
- Abstract
Background/aims: Crohn's disease is a risk factor for gallstone formation. In contrast, patients with ulcerative colitis have an incidence of gallstone formation comparable to the general population. The reason for this difference is not known. The aim of this study was to elucidate the factors controlling cholesterol crystallization in gallbladder bile of Crohn's disease and ulcerative colitis patients., Methods: Gallbladder bile was obtained by aspiration during bowel resections (26 Crohn's disease patients, 20 ulcerative colitis patients). Biliary lipid composition, crystal detection time and the effect of extraction of the concanavalin A-binding fraction on crystal formation were determined., Results: Cholesterol crystals were present in seven of the 26 bile samples of Crohn's disease-patients and one of the 20 ulcerative colitis patients. Four of the bile samples of Crohn's disease patients were fast nucleating. None of the 20 ulcerative colitis patients had fast nucleating bile. Lipid composition, total lipid concentration and CSI were not significantly different between the two groups. In Crohn's disease patients extraction of concanavalin A-binding fraction decreased crystallization in 10 bile samples but accelerated crystallization in one bile sample. In eight bile samples from ulcerative colitis patients crystallization increased after concanavalin A-binding fraction extraction., Conclusions: Compared to ulcerative colitis patients, gallbladder bile of Crohn's disease patients showed increased cholesterol crystallization despite comparable lipid composition and cholesterol saturation index. This difference is caused by increased cholesterol crystallization-promoting activity. Bile from ulcerative colitis patients contains a Con A-binding factor which inhibits cholesterol crystallization.
- Published
- 1999
- Full Text
- View/download PDF
47. [Bile duct injuries after a laparoscopic cholecystectomy].
- Author
-
Gouma DJ, Rauws EA, Keulemans YC, Bergman JJ, Huibregtse K, and Obertop H
- Subjects
- Adult, Bile Ducts diagnostic imaging, Cholangiography methods, Cholecystectomy, Laparoscopic methods, Female, Humans, Male, Middle Aged, Postoperative Complications therapy, Radionuclide Imaging, Reoperation, Ultrasonography, Bile Ducts injuries, Cholecystectomy, Laparoscopic adverse effects, Postoperative Complications diagnosis
- Abstract
Eight years after the introduction of laparoscopic cholecystectomy a decrease of the incidence of bile duct injuries is reported in the literature. The incidence of a bile duct injury after laparoscopic cholecystectomy is now slightly higher than after open cholecystectomy. A minority of these injuries are detected during surgery. Most patients have a delayed identification of the bile duct injury, even after discharge from the hospital. An early diagnostic work-up with ultrasound and endoscopic retrograde cholangiopancreatography (ERCP) is mandatory in every patient with persisting symptoms (more than 48 hours) after laparoscopic cholecystectomy. Still, one-third of the patients are subjected to a 'diagnostic' exploratory laparotomy without preoperative visualization of the biliary tract by ERCP or percutaneous transhepatic cholangiography. Minor lesions are mostly treated successfully by endoscopy with a stent. After transection of the bile duct surgical reconstruction by a hepaticojejunostomy has to be performed. A delayed elective reconstruction was associated with fewer complications than acute repair under suboptimal circumstances such as local inflammatory changes and bile leakage.
- Published
- 1999
48. Laparoscopic cholecystectomy: day-care versus clinical observation.
- Author
-
Keulemans Y, Eshuis J, de Haes H, de Wit LT, and Gouma DJ
- Subjects
- Adult, Aged, Feasibility Studies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Postoperative Complications epidemiology, Quality of Life, Ambulatory Surgical Procedures, Cholecystectomy, Laparoscopic, Hospitalization
- Abstract
Objective: To determine the feasibility and desirability of laparoscopic cholecystectomy (LC) in day-care versus LC with clinical observation., Summary Background Data: Laparoscopic cholecystectomy has been performed regularly as outpatient surgery in patients with uncomplicated gallstone disease in the United States, but this has not been generally accepted in Europe. The main objections are the risk of early severe complications (bleeding) or other reasons for readmission, and the argument that patients might feel safer when observed for one night. Quality-of-life differences hitherto have not been investigated., Methods: Eighty patients (American Society of Anesthesiology [ASA] I/II) with symptomatic gallstones were randomized to receive LC either in day-care or with clinical observation. Complications, (re)admissions, consultations of general practitioners or the day-care center within 4 days after surgery, use of pain medication, quality of life, convalescence period, time off from professional activities, and treatment preference were assessed. The respective costs of day-care and clinical observation were determined., Results: Of the 37 patients assigned to the day-care group who underwent elective surgery, 92% were discharged successfully after an observation period of 5.7+/-0.2 hours. The remainder of the patients in this group were admitted to the hospital and clinically observed for 24 hours. For the 37 patients in the clinical observation group who underwent elective surgery, the observation time after surgery was 31+/-3 hours. Three patients in the day-care group and one patient in the clinical observation group had complications after surgery. None of the patients in either group consulted a general practitioner or the hospital during the first week after surgery. Use of pain medication was comparable in both groups over the first 48 hours after surgery. There were no differences in pain and other quality-of-life indicators between the groups during the 6 weeks of follow-up. Of the patients in the day-care group, 92% preferred day-care to clinical observation. The same percentage of patients in the clinical observation group preferred at least 24 hours of observation to day-care. Costs for the day-care patients were substantially lower (approximately $750/patient) than for the clinical observation patients., Conclusion: Effectiveness was equal in both patient groups, and both groups appeared to be satisfied with their treatment. Because no differences were found with respect to the other outcomes, day-care is the preferred treatment in most ASA I and II patients because it is less expensive.
- Published
- 1998
- Full Text
- View/download PDF
49. Improvement in the management of bile duct injuries?
- Author
-
Keulemans YC, Bergman JJ, de Wit LT, Rauws EA, Huibregtse K, Tytgat GN, and Gouma DJ
- Subjects
- Bile Ducts surgery, Cholangiopancreatography, Endoscopic Retrograde, Female, Humans, Intraoperative Complications classification, Intraoperative Complications diagnostic imaging, Intraoperative Complications therapy, Male, Middle Aged, Statistics, Nonparametric, Time Factors, Bile Ducts injuries, Cholecystectomy, Laparoscopic adverse effects
- Abstract
Background: Previous studies have suggested that improvements in diagnostic workup and treatment of bile duct injuries (BDI) sustained during laparoscopic cholecystectomy can be expected as experience increases with the laparoscopic procedure. Many published articles reported that early diagnosis, proper classification, and optimal timing of treatment of BDI increase the likelihood of successful treatment. This study determined whether diagnosis and management of BDI have improved over the years., Study Design: Between June 1990 and November 1996, 106 patients were diagnosed and treated in the Amsterdam Academic Medical Center for BDI sustained during laparoscopic cholecystectomy. Detailed information was obtained about peroperative findings, time interval from laparoscopic cholecystectomy to symptoms, and interval from symptoms to diagnosis. Bile duct injuries were classified into four types. Two patient groups were compared: BDI patients diagnosed from 1990 until 1994 ("learning phase") and patients diagnosed from 1995 until 1996., Results: Bile duct injuries combined with bile leakage were diagnosed significantly earlier in the second period after the learning phase. The percentages of injuries diagnosed peroperatively, "blind laparotomies," and suboptimal timed hepaticojejunostomies were not different between the groups., Conclusions: Except for earlier diagnosis of BDI in the later period than in previous years, there appeared to be no significant improvement in diagnostic workup and management during the past 2 years.
- Published
- 1998
- Full Text
- View/download PDF
50. Hepatic bile versus gallbladder bile: a comparison of protein and lipid concentration and composition in cholesterol gallstone patients.
- Author
-
Keulemans YC, Mok KS, de Wit LT, Gouma DJ, and Groen AK
- Subjects
- Epithelium chemistry, Female, Humans, Immunoglobulin G analysis, Lipids analysis, Male, Middle Aged, Mucins analysis, Osmolar Concentration, Proteins analysis, Serum Albumin analysis, Bile chemistry, Cholelithiasis chemistry, Cholesterol analysis, Gallbladder chemistry, Liver chemistry
- Abstract
Many studies have demonstrated that gallbladder bile (but not hepatic bile) of animals or patients with cholesterol gallstones contains higher protein concentrations than does gallbladder bile of control patients without stones or with pigment stones. The underlying defect has not been elucidated. To establish whether there is net production or net absorption/degradation of protein by gallbladder epithelium for different classes of protein, paired samples of hepatic and gallbladder bile were obtained from fourteen patients with cholesterol gallstones during elective cholecystectomy. In these paired samples, lipid and protein composition were determined. To obtain the concentration ratio (CR) of protein and lipid, its concentration in the gallbladder was divided by the concentration determined in the paired hepatic bile sample. The CR of bile salts was used as a parameter for water absorption in the gallbladder. Of the biliary proteins that were determined only mucin, albumin, immunoglobulin (Ig) G, and aminopeptidase N appeared to increase in the gallbladder from another cause than water absorption. A strong correlation was found between mucin, albumin, and IgG. Haptoglobin, alpha1-acid glycoprotein, IgM, and IgA appeared to be absorbed by gallbladder epithelium in the majority of patients. In cholesterol gallstone patients, total protein concentration in gallbladder bile of cholesterol gallstone patients is increased when compared with hepatic bile. The increase in protein concentration cannot be explained for all bile samples solely by water absorption. In this study we show that the defect is largely caused by a selective increase in albumin, mucin, and IgG. All other proteins which were investigated are taken up by the gallbladder.
- Published
- 1998
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.